(0.28%) 5 114.24 points
(0.22%) 38 324 points
(0.30%) 15 976 points
(-1.47%) $82.62
(3.69%) $1.994
(0.02%) $2 347.70
(0.10%) $27.56
(3.50%) $954.40
(-0.13%) $0.933
(-0.26%) $11.00
(-0.43%) $0.797
(1.72%) $93.45
Live Chart Being Loaded With Signals
Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity...
Stats | |
---|---|
今日成交量 | 13.86M |
平均成交量 | 462 154 |
市值 | 183.73M |
EPS | £0 ( 2024-04-22 ) |
Last Dividend | £0 ( N/A ) |
Next Dividend | £0 ( N/A ) |
P/E | 12.91 |
ATR14 | £2.89 (2.03%) |
音量 相关性
Arix Bioscience PLC 相关性 - 货币/商品
Arix Bioscience PLC 财务报表
Annual | 2022 |
营收: | £112 000 |
毛利润: | £112 000 (100.00 %) |
EPS: | £-0.210 |
FY | 2022 |
营收: | £112 000 |
毛利润: | £112 000 (100.00 %) |
EPS: | £-0.210 |
FY | 2021 |
营收: | £340 000 |
毛利润: | £0.00 (0.00 %) |
EPS: | £-0.582 |
FY | 2020 |
营收: | £477 000 |
毛利润: | £0.00 (0.00 %) |
EPS: | £0.968 |
Financial Reports:
No articles found.
Arix Bioscience PLC
Arix Bioscience plc is a venture capital firm specializing in all stages of growth, seed stage, preclinical and clinical stage assets, startup, early stage, mid venture, late stage, growth capital investments as well as private and public equity. The firm seeks to invest in biotech companies, novel therapeutics, innovative technologies, medical innovation comprising healthcare and life sciences. It seeks to invest globally. The firm employs an evergreen approach to funding. It primarily makes investments from its own balance sheet. The firm prefers to take board seat. The firm exit when the optimum value has been reached. Arix Bioscience plc is formerly known as Perceptive Bioscience Investments Limited. Arix Bioscience plc was founded in 2015 and is based in London, United Kingdom.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。